| Bioactivity | JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1]. |
| Name | JAK-IN-35 |
| CAS | 936091-15-5 |
| Formula | C26H34N6O3S |
| Molar Mass | 510.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1. |